Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 3
1(20.0%)
5Total
N/A(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07166692Not ApplicableCompleted

Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology

Role: collaborator

NCT07493421Not ApplicableRecruiting

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Role: collaborator

NCT04271579Not ApplicableRecruiting

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)

Role: collaborator

NCT07294794Not ApplicableNot Yet Recruiting

Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension

Role: collaborator

NCT07012629Phase 3Recruiting

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Role: collaborator

NCT07111975Active Not Recruiting

ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction

Role: collaborator

All 6 trials loaded